A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort
Chikako Ohwada(Chiba University), Shinichiro Okamoto(Keio University), Masako Toyosaki(Tokai University), Emiko Sakaida(Chiba University Hospital), Shin Fujisawa(Yokohama City University Medical Center), Noriko Doki(Tokyo Metropolitan Komagome Hospital), Takayoshi Tachibana(Yokohama City University), Takeshi Kobayashi(Nihon Institute of Medical Science), Katsuhiro Shono(Chiba Aoba Municipal Hospital), Maki Hagihara(Yokohama City University Hospital), Hideki Nakasone(Jichi Medical University), Takehiko Mori(Keio University), Aiko Igarashi(Tokyo Metropolitan Komagome Hospital), Heiwa Kanamori(Kanagawa Prefectural Hospital Organization), Chiaki Nakaseko(Chiba University), Hiroaki Shimizu, Makoto Onizuka(Tokai University), Yuya Koda(Keio University), Ayumi Numata(Yokohama City University Medical Center), Jun Kato(Keio University), Reiko Watanabe(Tokyo National Hospital), Takeshi Saito(Jikei University School of Medicine), Satoshi Koyama(Yokohama City University), Yuki Nakajima(Fujisawa City Hospital), Rika Sakai(Yokohama City University Medical Center), Seiko Kato(Tokyo Medical University), Masatsugu Tanaka(Kanagawa Prefectural Hospital Organization), Yasuyuki Aoyama(Tokai University), Yoshinobu Kanda(Jichi Medical University)
Cited by 13
Related Papers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study
|Cancer Science|2019|375
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
|Biology of Blood and Marrow Transplantation|2011|363